DHEA and progesterone have a protective effect on ribavirin-induced hemolysis.
暂无分享,去创建一个
[1] C. Datz,et al. Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients. , 2013, Journal of hepatology.
[2] G. Duverlie,et al. A New Tool to Study Ribavirin-Induced Haemolysis , 2012, Antiviral therapy.
[3] P. Kwo,et al. Anemia management in the era of triple combination therapy for chronic HCV. , 2012, Gastroenterology & hepatology.
[4] T. Mune,et al. Changes in serum sex hormone profiles after short-term low-dose administration of dehydroepiandrosterone (DHEA) to young and elderly persons. , 2007, Endocrine journal.
[5] Y. Matsuzaki,et al. Erythrocyte ribavirin concentration for assessing hemoglobin reduction in interferon and ribavirin combination therapy. , 2006, Hepatology research : the official journal of the Japan Society of Hepatology.
[6] A. Leplège,et al. Double‐blind placebo‐controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease , 2001, Clinical endocrinology.
[7] G. Fattovich,et al. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damage , 2000, Hepatology.